Abstract
Infection following total hip arthroplasty (THA) represents a devastating complication and is one of the main causes for revision surgery. This complication may be treated by irrigation and debridement with head and polyethylene exchange (IDHPE) or a two-stage revision (2SR). Previous studies have reported on the eradication success rates but few have reported patient outcome scores. The purpose of this study was to report patient outcome scores for both IDHPE and 2SR and compare these to a non-infected matched cohort. We hypothesised that both cohorts would have worse outcomes than the control group, and that those who failed an initial IDHPE and required a 2SR would have a worse outcome than those treated initially with a 2SR.
A retrospective review identified 137 patients from our institutional arthroplasty database who had an infected primary THA between 1986–2013. We excluded patients with less than one-year follow-up. Mean follow-up was 60 months (12–187 months). A control cohort was identified and matched according to age and Charlton Comorbidity Index (CCI). Harris Hip Scores, Short Form 12 and WOMAC scores were compared between our control group and our infected cohort.
Sixty-eight patients were treated with a 2SR and 69 patients were treated with an IDHPE. There was a 59% success rate in eradicating the infection with an IDHPE. All of the 28 patients who failed an IDHPE later went on to a 2SR. Outcome scores for the 2SR cohort were significantly worse than the non-infected controls (p0.05). There was no difference in outcome scores when comparing our 2SR cohort to our failed IDHPE (p>0.05).
Previous studies have focused on eradication rates. However, it is important to consider patient outcome scores when deciding the best treatment. Infected patients treated with a successful IDHPE had similar outcomes to non-infected patients. Patients that failed IDHPE and went onto 2SR had similar outcomes to those that had a 2SR alone. IDHPE should still be considered in the treatment algorithm of infected THA.
